Which is better, IR or MYCR.ST?

On the Buffett-Fit framework, Mycronic AB (publ) (MYCR.ST) currently grades higher than IR — 77/100 (B grade) vs 49/100 (D). That said, "better" depends on which framework you trust — IR wins on none; MYCR.ST wins on Warren Buffett, Benjamin Graham, Philip Fisher, Peter Lynch, Joel Greenblatt, Charlie Munger, and Terry Smith. The full pillar breakdown is on this page.

Should I buy IR or MYCR.ST?

This page is an educational comparison, not investment advice. Both IR and MYCR.ST are graded against the same Buffett 5-pillar framework (moat, earnings durability, management quality, financial health, valuation) plus six other documented investor frameworks. Read the side-by-side breakdown to see which one matches the criteria you care about most — and always do your own research before making any investment decision.

Is IR better than MYCR.ST for value investing?

On the Buffett-style value-investing framework, MYCR.ST currently grades higher — 77/100 vs 49/100, a 28-point gap. The gap is driven by which pillars each stock passes; the table on this page shows moat, durability, management, financial health, and valuation side-by-side.

What's the difference between IR and MYCR.ST on Warren Buffett's framework?

Both stocks are evaluated on the same five pillars: economic moat (durable competitive advantage), earnings durability (consistent profitability), management quality (capital allocation), financial health (conservative balance sheet), and valuation (margin of safety). IR currently scores 49/100 (D grade); MYCR.ST scores 77/100 (B grade). The "Where each wins" section on this page breaks down which pillar each stock dominates.

Which has the stronger moat, IR or MYCR.ST?

Moat strength is one of the five pillars in the Buffett-Fit score on this page. IR and MYCR.ST are each scored on ROIC sustainability, gross-margin durability, and qualitative signals like brand strength, switching costs, network effects, and regulatory barriers. The pillar breakdown on this page shows the moat sub-score side-by-side so you can see which one has the more durable competitive advantage.

Which is more undervalued, IR or MYCR.ST?

Valuation is one of the five Buffett-Fit pillars on this page. Both stocks are scored on owner-earnings yield, price-to-intrinsic-value vs the underlying compounding rate, and the margin of safety relative to a conservative DCF. The valuation sub-score in the table below tells you which one currently trades at a more attractive price relative to its underlying business quality.

Are IR and MYCR.ST both Industrials stocks?

Yes — both Ingersoll Rand Inc. (IR) and Mycronic AB (publ) (MYCR.ST) operate in the Industrials sector. That makes this a direct sector-peer comparison, which is the apples-to-apples way to use the Buffett-Fit framework: the score weighs each stock against its sector's specific quality and valuation benchmarks (sector-relative bonus), so the cross-stock comparison isn't distorted by inter-sector base-rate differences.

Is this IR vs MYCR.ST comparison investment advice?

No. This page is an educational pattern-match against documented public frameworks (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith), not personalised investment advice. The scores reflect how closely each stock matches each framework's documented criteria — they are not buy/hold/sell recommendations. Always do your own research and consult a licensed financial adviser for personalised advice.

Stock comparison

Ingersoll Rand

IR$29.99BIndustrials Market cap, Sector

Mycronic AB (publ)

MYCR.ST$58.89BIndustrials Market cap, Sector

Overall winner

Mycronic AB (publ)

IR 07 MYCR.ST

Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.

Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.

Fit scores by strategy

IR0wins

7winsMYCR.ST

Warren Buffett

49D

B77

Benjamin Graham

75B

A85

Philip Fisher

41F

A85

Peter Lynch

50D

C69

Joel Greenblatt

28F

C66

Charlie Munger

37F

B78

Terry Smith

42F

B77

Side-by-side metrics

Metric	IR	MYCR.ST
Market cap	$29.99B	$58.89B Winner
P/E (TTM)	47.0x	37.5x Winner
EV/EBIT	Winner: 18.5x	29.1x
ROIC (TTM)	6.48%	20.79% Winner
Gross margin	38.24%	52.44% Winner
Net margin	7.54%	19.65% Winner
Revenue CAGR 5y	10.39%	15.75% Winner
EPS CAGR 5y	1.79%	28.15% Winner
Debt / Equity	Winner: 0.0x	0.0x
Dividend yield	0.11%	-

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

IR leads on

Debt / Equity0.0xvs 0.0x+100%
EV/EBIT18.5xvs 29.1x+36%

MYCR.ST leads on

EPS CAGR 5y28.15%vs 1.79%+94%
ROIC (TTM)20.79%vs 6.48%+69%
Net margin19.65%vs 7.54%+62%
Market cap$58.89Bvs $29.99B+49%

More like IR

IR vs 6532.T IR vs SALIK.AE IR vs CTAS IR vs GPP.WA

More like MYCR.ST

MYCR.ST vs 6532.T MYCR.ST vs SALIK.AE MYCR.ST vs CTAS MYCR.ST vs GPP.WA

Read the full Buffett-Brain analysis for IR Read the full Buffett-Brain analysis for MYCR.ST

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

Key terms in this analysis

ROIC Free Cash Flow (FCF)Economic Moat P/E Ratio Margin of Safety Quality Score

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.

Stock comparison

Ingersoll Rand

IR$29.99BIndustrials Market cap, Sector

Mycronic AB (publ)

MYCR.ST$58.89BIndustrials Market cap, Sector

Overall winner

Mycronic AB (publ)

IR 07 MYCR.ST

Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.

Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.

Fit scores by strategy

IR0wins

7winsMYCR.ST

Warren Buffett

49D

B77

Benjamin Graham

75B

A85

Philip Fisher

41F

A85

Peter Lynch

50D

C69

Joel Greenblatt

28F

C66

Charlie Munger

37F

B78

Terry Smith

42F

B77

Side-by-side metrics

Metric	IR	MYCR.ST
Market cap	$29.99B	$58.89B Winner
P/E (TTM)	47.0x	37.5x Winner
EV/EBIT	Winner: 18.5x	29.1x
ROIC (TTM)	6.48%	20.79% Winner
Gross margin	38.24%	52.44% Winner
Net margin	7.54%	19.65% Winner
Revenue CAGR 5y	10.39%	15.75% Winner
EPS CAGR 5y	1.79%	28.15% Winner
Debt / Equity	Winner: 0.0x	0.0x
Dividend yield	0.11%	-

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

IR leads on

Debt / Equity0.0xvs 0.0x+100%
EV/EBIT18.5xvs 29.1x+36%

MYCR.ST leads on

EPS CAGR 5y28.15%vs 1.79%+94%
ROIC (TTM)20.79%vs 6.48%+69%
Net margin19.65%vs 7.54%+62%
Market cap$58.89Bvs $29.99B+49%

More like IR

IR vs 6532.T IR vs SALIK.AE IR vs CTAS IR vs GPP.WA

More like MYCR.ST

MYCR.ST vs 6532.T MYCR.ST vs SALIK.AE MYCR.ST vs CTAS MYCR.ST vs GPP.WA

Read the full Buffett-Brain analysis for IR Read the full Buffett-Brain analysis for MYCR.ST

Related on invest-like

Strongest Moat Highest ROIC Warren Buffett strategy Economic Moat

Key terms in this analysis

ROIC Free Cash Flow (FCF)Economic Moat P/E Ratio Margin of Safety Quality Score

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.